Search

everythinglearnresearchcommunity

for

Search:↓

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Ultraviolet rays damage hair, smoking may cause hair loss, and good nutrition is important for hair health, but genetics mainly decide hair thickness.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Bioluminescence imaging can track hair follicle cells and help study hair regrowth.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Prolactin affects when mice shed and grow hair.

Alternative treatments show promise for hair growth beyond traditional methods.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Dermoscopy effectively diagnoses and evaluates female hair loss treatment.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

Finasteride affects SRD5A2 gene pattern, possibly causing lasting side effects.

Androgens can both increase body hair and cause scalp hair loss.